Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: implications for timing of antiretroviral therapy.
about
Genome-wide association study identifies single nucleotide polymorphism in DYRK1A associated with replication of HIV-1 in monocyte-derived macrophagesHIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy.Current estimates for HIV-1 production imply rapid viral clearance in lymphoid tissuesHuman Immunodeficiency Virus Playing Hide-and-Seek: Understanding the TFH Cell Reservoir and Proposing Strategies to Overcome the Follicle SanctuaryThe Development and Implementation of an Outreach Program to Identify Acute and Recent HIV Infections in New York City.Cellular HIV-1 DNA levels in patients receiving antiretroviral therapy strongly correlate with therapy initiation timing but not with therapy durationHuman immunodeficiency virus pathogenesis and prospects for immune control in patients with established infection.Cell-cell spread of human immunodeficiency virus type 1 overcomes tetherin/BST-2-mediated restriction in T cells.Human immunodeficiency virus pathogenesis: insights from studies of lymphoid cells and tissues.Dendritic-cell interactions with HIV: infection and viral dissemination.Nevirapine resistance by timing of HIV type 1 infection in infants treated with single-dose nevirapine.Surrogacy in antiviral drug development.Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapiesEvaluation of atazanavir and darunavir interactions with lipids for developing pH-responsive anti-HIV drug combination nanoparticlesLarge number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption.Influence of follicular dendritic cells on HIV dynamics.Acute HIV revisited: new opportunities for treatment and prevention.Immunohistochemical localization of feline immunodeficiency virus using native species antibodiesFollicular regulatory T cells impair follicular T helper cells in HIV and SIV infection.Perils at mucosal front lines for HIV and SIV and their hosts.Development of NanoART for HIV Treatment: Minding the Cytochrome P450 (CYP) EnzymesHIV reservoirs and latency models.Fetal immune activation to malaria antigens enhances susceptibility to in vitro HIV infection in cord blood mononuclear cellsSystems Approach to targeted and long-acting HIV/AIDS therapy.TFH in HIV Latency and as Sources of Replication-Competent VirusCell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells.Nanodrug formulations to enhance HIV drug exposure in lymphoid tissues and cells: clinical significance and potential impact on treatment and eradication of HIV/AIDS.Defining HIV and SIV Reservoirs in Lymphoid Tissues.Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir sizeHIV DNA Is Frequently Present within Pathologic Tissues Evaluated at Autopsy from Combined Antiretroviral Therapy-Treated Patients with Undetectable Viral Loads.Simian Immunodeficiency Virus-Producing Cells in Follicles Are Partially Suppressed by CD8+ Cells In Vivo.Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues.T cell polarization at the virological synapse.Mechanisms of HIV persistence in HIV reservoirs.In Vivo Models of Human Immunodeficiency Virus Persistence and Cure Strategies.Detachment of human immunodeficiency virus type 1 from germinal centers by blocking complement receptor type 2.Establishment and Reversal of HIV-1 Latency in Naive and Central Memory CD4+ T Cells In Vitro.Presence of host ICAM-1 in laboratory and clinical strains of human immunodeficiency virus type 1 increases virus infectivity and CD4(+)-T-cell depletion in human lymphoid tissue, a major site of replication in vivo.Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis.How germinal centers evolve broadly neutralizing antibodies: the breadth of the follicular helper T cell response.
P2860
Q21135536-4C4C2DD6-675C-425D-BF4F-6DC73EB19DEDQ33598231-E53A8184-5E61-461E-A90C-FF568D65CCE4Q33687055-E77524A4-6EE0-4F51-884E-CE974A5B1073Q33742139-AD588102-D85D-46D6-B305-FD52C3DC0CE0Q33779354-7408E752-74FE-4825-AADB-45E6E4D33DD7Q33909555-61F955F3-C395-4FE2-9250-3DAE3D18F6D3Q34255654-6823E2F1-1A75-4831-9916-3639F0F96126Q34291056-E27A8683-AB4A-4228-89EB-7391CA0E11DDQ34341001-B86F8927-44E2-4436-AF81-38A415EC6F95Q34572043-8546879D-B7B2-4F07-933B-4206C23E8A59Q34572571-CD95E609-BA60-4265-B108-9EA1BFD38EE9Q34722747-56A5C1B4-32F0-4719-AB11-43CE575C2D49Q34797004-CB449BFF-C136-47C8-A8F3-493A545EE1A0Q35147145-E3733423-877F-49F3-92B6-96F5E8DA2EE5Q35190018-D5B1BA97-7A44-42D7-AB0D-BA66757FC0F0Q35212759-7D79AB9A-E9EA-4C9A-89AA-926C7C7F6698Q35730339-1CA42880-CBD1-45E0-8E0A-B14094FB8E49Q35789227-F229A339-E4DF-47A5-8E12-7728E81FC11EQ36192967-35AA9260-DF9A-42F9-95BD-E72DB34F6A67Q36274922-21B014AE-1BA0-4B9E-A58C-EAC1A85D8B85Q36338109-1BC541A4-5DAC-41D2-9830-BB4DE8B9E95FQ36746403-0787557F-DE84-4F82-97AD-10332132A9A5Q36749601-9327DAAA-7ED2-4B7E-AD85-635CFF10963DQ36783298-7F2B9261-911A-4D9E-862F-44A4EA7630B3Q36827343-8938CD79-5708-440A-BB7A-2182F534EEA5Q36882465-41C68AB2-49A6-4931-99E1-81F92F3C4418Q37013364-4C4547CD-E976-4299-997B-1C7715326E82Q37090999-1AE2E43E-467C-4FBA-B909-6260D92FDA06Q37187501-C799F2C9-DF3F-4F6E-ADDA-65F9957C33A4Q37300347-598BCC6C-AEB9-4411-9B73-C626EA0091B6Q37448333-E6A0BC15-0B5D-4DA9-8CE3-84CC5E427F6AQ37587740-61D0B106-C1F9-41B7-A0AD-B792EF8CC88BQ37945207-E60FFC46-88A2-462C-91FA-98E09E07A43BQ39106572-318CE467-F85A-4974-A957-CA404DBC5080Q39315707-F532D7E2-AAFA-4B0C-A0FF-A990376E3DB4Q39593041-A4034688-25DB-4D93-8248-69938992F683Q39645005-1F2D1A93-256B-4F0C-9ED8-FB5F91EA2C7EQ39682314-50E2A6AD-8681-446B-BF11-BC3C11417792Q39737305-27AB5591-B7AE-40B1-B330-450D2D2D9D5EQ40054979-85A8BD12-F590-4664-91C7-F17584818B20
P2860
Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: implications for timing of antiretroviral therapy.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Rapid accumulation of human im ...... ing of antiretroviral therapy.
@en
Rapid accumulation of human immunodeficiency virus
@nl
type
label
Rapid accumulation of human im ...... ing of antiretroviral therapy.
@en
Rapid accumulation of human immunodeficiency virus
@nl
prefLabel
Rapid accumulation of human im ...... ing of antiretroviral therapy.
@en
Rapid accumulation of human immunodeficiency virus
@nl
P2093
P356
P1476
Rapid accumulation of human im ...... ing of antiretroviral therapy.
@en
P2093
Gebhard-Mitchell K
Schacker T
P304
P356
10.1086/315178
P407
P50
P577
2000-01-01T00:00:00Z